Velgene

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Samsara Therapeutics

This company develops autophagy-activating small molecule therapeutics to treat neurodegenerative and age-related diseases for patients with conditions such as ALS and Parkinson’s.

Trimtech Therapeutics

This biotechnology company develops small molecule drugs that target and degrade toxic protein aggregates to treat neurodegenerative and inflammatory diseases.

Vandria

This biopharmaceutical company develops small molecule mitophagy inducers to treat patients with age-related and chronic diseases, specifically targeting neurodegenerative and muscle disorders.

Sentonix

This company develops small-molecule drugs to treat neurodegenerative disorders for patients with unmet medical needs.

Vanqua Bio

This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.

AstronauTx

This biotechnology company develops small-molecule drugs targeting astrocyte biology to treat patients with Alzheimer's disease and other neurodegenerative disorders.

AbilityPharma

This company develops autophagy-inducing oral therapies for patients with various forms of cancer, including pancreatic, endometrial and lung cancer.